Sprinzen, L.; Garcia, F.; Mela, A.; Lei, L.; Upadhyayula, P.; Mahajan, A.; Humala, N.; Manier, L.; Caprioli, R.; Quiñones-Hinojosa, A.;
et al. EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor. Cells 2024, 13, 219.
https://doi.org/10.3390/cells13030219
AMA Style
Sprinzen L, Garcia F, Mela A, Lei L, Upadhyayula P, Mahajan A, Humala N, Manier L, Caprioli R, Quiñones-Hinojosa A,
et al. EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor. Cells. 2024; 13(3):219.
https://doi.org/10.3390/cells13030219
Chicago/Turabian Style
Sprinzen, Lisa, Franklin Garcia, Angeliki Mela, Liang Lei, Pavan Upadhyayula, Aayushi Mahajan, Nelson Humala, Lisa Manier, Richard Caprioli, Alfredo Quiñones-Hinojosa,
and et al. 2024. "EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor" Cells 13, no. 3: 219.
https://doi.org/10.3390/cells13030219
APA Style
Sprinzen, L., Garcia, F., Mela, A., Lei, L., Upadhyayula, P., Mahajan, A., Humala, N., Manier, L., Caprioli, R., Quiñones-Hinojosa, A., Casaccia, P., & Canoll, P.
(2024). EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor. Cells, 13(3), 219.
https://doi.org/10.3390/cells13030219